3 excellent Australian tech stocks to buy before they rebound

Analysts have put buy ratings on these fallen stars.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Australian tech stocks have been under pressure recently. Concerns about interest rates, valuations, and the potential disruptive impact of artificial intelligence (AI) on parts of the software industry have weighed on sentiment.

However, market pullbacks can sometimes create opportunities for long-term investors.

When high-quality stocks sell off alongside the broader sector, patient investors may be able to pick up strong businesses at more attractive prices.

With that in mind, here are three excellent Australian tech stocks that analysts think could be worth considering before sentiment improves.

Happy man and woman looking at the share price on a tablet.

Image source: Getty Images

Pro Medicus Ltd (ASX: PME)

The first Australian tech stock that could be ready to rebound is Pro Medicus.

Pro Medicus develops advanced medical imaging software used by hospitals and healthcare providers around the world. Its Visage platform enables radiologists to process and analyse complex medical scans much faster than traditional systems, improving efficiency and clinical outcomes.

The company's incredible growth over the past decade has been driven by long-term contracts with major hospital networks. Once its platform is installed, switching providers can be difficult, which creates strong customer retention and recurring revenue.

Medical imaging volumes continue to grow as healthcare systems become more data-driven and diagnostic demand increases. With a strong pipeline of hospital tenders, a reputation for best-in-class technology, and expansion into other ologies, Pro Medicus still appears to have a very long growth runway.

Morgans currently rates Pro Medicus as a buy with a $275.00 price target.

TechnologyOne Ltd (ASX: TNE)

Another Australian tech stock that could bounce back strongly is TechnologyOne.

TechnologyOne provides enterprise software to government agencies, universities, and large organisations. Its cloud platform helps customers manage finance, payroll, asset management, and other critical systems.

Over recent years, the company has successfully transitioned its business toward a software-as-a-service model. This shift has increased recurring revenue and improved earnings visibility.

With the ongoing migration to the cloud and new AI-driven features being added to its software suite, the company appears well positioned to continue growing over the long term.

Ord Minnett recently put a buy rating and $30.54 price target on its shares.

WiseTech Global Ltd (ASX: WTC)

A third Australian tech stock that could rebound is WiseTech Global.

WiseTech develops logistics software used by freight forwarders, shipping companies, and supply chain operators around the world. Its CargoWise platform helps manage the complex movement of goods across borders, customs systems, and transportation networks.

Global trade is becoming increasingly digital, and logistics companies rely on sophisticated software platforms to manage compliance, documentation, and operations. WiseTech's CargoWise system has become a critical tool for many large freight operators.

Looking ahead, the opportunity tied to the digitalisation of global trade remains substantial, which bodes well for its growth outlook.

Bell Potter has a buy rating and $83.75 price target on its shares.

Motley Fool contributor James Mickleboro has positions in Pro Medicus, Technology One, and WiseTech Global. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Technology One and WiseTech Global. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended WiseTech Global. The Motley Fool Australia has recommended Pro Medicus and Technology One. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Technology Shares

Business people discussing project on digital tablet.
Technology Shares

Should I buy WiseTech shares? Yes or no

A major sell-off has pushed the logistics software company’s shares significantly lower.

Read more »

A silhouette of a soldier flying a drone at sunset.
Technology Shares

Electro Optic Systems shares jump on new Middle East contract win

Interest in anti-drone technology appears to be picking up.

Read more »

A player pounces on the ball in the scoring zone of the field.
Technology Shares

What's going on with this ASX tech share?

Morgans sees 80% upside, despite the sports stock plummeting 50%.

Read more »

A young woman with her mouth open and her hands out showing surprise and delight as uranium share prices skyrocket
Growth Shares

$10,000 invested in Droneshield and Woodside shares just 1 week ago is now worth…

And here's what the analysts expect from these two ASX 200 stocks next.

Read more »

A woman in colourful outfit holds up a phone to take a selfie.
Technology Shares

3 ASX tech shares to buy amid ongoing tech wreck

There have been some signs of stabilisation in the tech sector since mid-February, so is it time to buy the…

Read more »

A blue globe outlined against a black background.
Technology Shares

A rare buying opportunity in 1 of Australia's top shares?

I think this business looks too cheap to miss.

Read more »

Two IT professionals walk along a wall of mainframes in a data centre discussing various things
Technology Shares

This All Ords technology stock could shoot the lights out: broker

The company was valued at $1.73 billion at Wednesday's close.

Read more »

Group of stressful businesspeople having problems. sittong around a desk.
Technology Shares

Why are EOS shares crashing 10% today?

This popular stock is having a rough day. Let's find out why.

Read more »